Sicart Associates LLC Merck & Co., Inc. Transaction History

Sicart Associates LLC

$272 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $1.35 Million - $1.51 Million	-13,148 Reduced 12.79%	89,677 $9.54 Million
Q4 2022 Jan 27, 2023	SELL	$87.44 - $112.11 $62,082 - $79,598	-710 Reduced 0.69%	102,825 $0
Q3 2022 Nov 01, 2022	SELL	$84.53 - $94.96 $1.71 Million - $1.92 Million	-20,257 Reduced 16.36%	103,535 $8.99 Million
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $117,052 - $132,685	1,402 Added 1.15%	123,792 $11.4 Million
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $274,045 - $307,187	-3,728 Reduced 2.96%	122,390 $10.1 Million
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $435,631 - $545,684	6,027 Added 5.02%	126,118 $9.82 Million
Q3 2021 Oct 22, 2021	SELL	$71.68 - $78.83 $935,424 - $1.03 Million	-13,050 Reduced 9.8%	120,091 $9.1 Million
Q2 2021 Jul 23, 2021	BUY	$70.31 - $77.77 $4.31 Million - $4.77 Million	61,365 Added 85.5%	133,141 $10.4 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $348,087 - $410,011	-5,055 Reduced 6.58%	71,776 $5.58 Million
Q4 2020 Jan 22, 2021	SELL	$71.77 - $79.65 $83,324 - $92,473	-1,161 Reduced 1.49%	76,831 $6.33 Million
Q3 2020 Oct 14, 2020	SELL	$73.18 - $82.95 $98,793 - $111,982	-1,350 Reduced 1.7%	77,992 $6.52 Million
Q2 2020 Jul 30, 2020	SELL	$70.42 - $80.13 $76,405 - $86,941	-1,085 Reduced 1.35%	79,342 $6.18 Million
Q1 2020 Apr 22, 2020	SELL	$63.36 - $87.82 $262,310 - $363,574	-4,140 Reduced 4.9%	80,427 $6.24 Million
Q4 2019 Jan 30, 2020	SELL	$77.58 - $87.54 $288,209 - $325,211	-3,715 Reduced 4.21%	84,567 $7.74 Million
Q3 2019 Oct 21, 2019	BUY	$76.08 - $82.93 $255,096 - $278,064	3,353 Added 3.95%	88,282 $7.48 Million
Q2 2019 Jul 23, 2019	SELL	$69.84 - $81.59 $256,662 - $299,843	-3,675 Reduced 4.15%	84,929 $7.17 Million
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $33,050 - $37,696	-475 Reduced 0.53%	88,604 $7.42 Million
Q4 2018 Jan 22, 2019	SELL	$65.24 - $75.71 $5,088 - $5,905	-78 Reduced 0.09%	89,079 $6.86 Million
Q2 2018 Jul 19, 2018	BUY	$50.83 - $59.72 $3.69 Million - $4.34 Million	72,630 Added 439.46%	89,157 $5.45 Million
Q1 2018 Apr 12, 2018	SELL	$50.96 - $59.23 $1.24 Million - $1.44 Million	-24,280 Reduced 59.5%	16,527 $908,000
Q4 2017 Jan 17, 2018	SELL	$51.62 - $61.64 $1.85 Million - $2.21 Million	-35,807 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$58.67 - $63.13 $2.1 Million - $2.26 Million	35,807	35,807 $2.29 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.6 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.8 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.52 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.87 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.

Account